115 related articles for article (PubMed ID: 23331559)
1. The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma.
Kent SE; Boyce M; Diamant Z; Singh D; O'Connor BJ; Saggu PS; Norris V
Clin Exp Allergy; 2013 Feb; 43(2):177-86. PubMed ID: 23331559
[TBL] [Abstract][Full Text] [Related]
2. Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils.
Chaudhuri R; Norris V; Kelly K; Zhu CQ; Ambery C; Lafferty J; Cameron E; Thomson NC
Pulm Pharmacol Ther; 2014 Feb; 27(1):62-9. PubMed ID: 24333186
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study.
Follows RM; Snowise NG; Ho SY; Ambery CL; Smart K; McQuade BA
Respir Res; 2013 May; 14(1):54. PubMed ID: 23682661
[TBL] [Abstract][Full Text] [Related]
4. The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction.
Kent SE; Bentley JH; Miller D; Sterling R; Menendez R; Tarpay M; Pearlman DS; Norris V
Allergy Asthma Proc; 2014; 35(2):126-33. PubMed ID: 24717789
[TBL] [Abstract][Full Text] [Related]
5. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study.
Singh D; Boyce M; Norris V; Kent SE; Bentley JH
Int J Gen Med; 2013; 6():897-903. PubMed ID: 24357936
[TBL] [Abstract][Full Text] [Related]
8. The allergen specificity of the late asthmatic reaction.
Hatzivlassiou M; Grainge C; Kehagia V; Lau L; Howarth PH
Allergy; 2010 Mar; 65(3):355-8. PubMed ID: 19804443
[TBL] [Abstract][Full Text] [Related]
9. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
[TBL] [Abstract][Full Text] [Related]
10. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
[TBL] [Abstract][Full Text] [Related]
11. A dual CysLT
Gauvreau GM; Boulet LP; FitzGerald JM; Cockcroft DW; Davis BE; Leigh R; Tanaka M; Fourre JA; Tanaka M; Nabata T; O'Byrne PM
Allergy; 2016 Dec; 71(12):1721-1727. PubMed ID: 27444660
[TBL] [Abstract][Full Text] [Related]
12. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Di Franco A; Costa F; Vagaggini B; Paggiaro PL
Ann Allergy Asthma Immunol; 2008 May; 100(5):457-62. PubMed ID: 18517078
[TBL] [Abstract][Full Text] [Related]
14. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor.
Bain G; King CD; Schaab K; Rewolinski M; Norris V; Ambery C; Bentley J; Yamada M; Santini AM; van de Wetering de Rooij J; Stock N; Zunic J; Hutchinson JH; Evans JF
Br J Clin Pharmacol; 2013 Mar; 75(3):779-90. PubMed ID: 22803688
[TBL] [Abstract][Full Text] [Related]
16. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
[TBL] [Abstract][Full Text] [Related]
18. Sputum levels of reduced glutathione increase 24 hours after allergen challenge in isolated early, but not dual asthmatic responders.
Beier J; Beeh KM; Semmler D; Buhl R
Int Arch Allergy Immunol; 2004 Sep; 135(1):30-5. PubMed ID: 15286443
[TBL] [Abstract][Full Text] [Related]
19. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
[TBL] [Abstract][Full Text] [Related]
20. Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens.
Boulet LP; Gauvreau G; Boulay ME; O'Byrne PM; Cockcroft DW
Clin Exp Allergy; 2015 Nov; 45(11):1647-53. PubMed ID: 26115509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]